Publication | Open Access

Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte

Rheumatoid DisorderPediatric EpidemiologyClinical EpidemiologyChildhood ArthritisInflammatory Rheumatic DiseasePublic HealthRheumatoid ArthritisRheumatologyAutoimmune DiseaseRheumatic DiseasesBiological AgentsPaediatric RheumatologyEpidemiologyPathogenesisJuvenile Idiopathic ArthritisPediatricsInfectious Adverse EventsMedicineSystemic Juvenile Idiopathic Arthritis